Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Last updated: December 20, 2018
Sponsor: Ipsen
Overall Status: Completed

Phase

N/A

Condition

Digestive System Neoplasms

Gastric Cancer

Carcinoid Syndrome And Carcinoid Tumours

Treatment

N/A

Clinical Study ID

NCT03017690
A-US-52030-358
  • Ages > 18
  • All Genders

Study Summary

An observational time and motion study in a clinical oncology setting is utilized in order to measure and compare product attributes and overall product efficiency between lanreotide and octreotide LAR.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Men and women must be 18 years of age or older

  • A current diagnosis of advanced, unresectable GEP-NET

  • Provided written informed consent to participate in the study

  • Currently receiving lanreotide or octreotide LAR and has received at least one priorinjection of current somatostatin analogues (SSA).

Exclusion

Exclusion Criteria:

  • Receiving treatment with lanreotide or octreotide LAR as part of a clinical trial

  • Scheduled to receive a dose of lanreotide or octreotide LAR that would necessitatemore than 1 injection on the same day

  • Scheduled to receive any other treatment in the infusion center/room on the same dayand as part of the same appointment

  • Known hypersensitivity to somatostatin analogues

Study Design

Total Participants: 22
Study Start date:
April 12, 2017
Estimated Completion Date:
May 30, 2018

Connect with a study center

  • The University of Arizona Cancer Center

    Tucson, Arizona 85719
    United States

    Site Not Available

  • The University of Arizona Cancer Center

    Tuscan, Arizona 85719
    United States

    Site Not Available

  • Ochsner Medical Center Kenner

    Kenner, Louisiana 70065
    United States

    Site Not Available

  • Mercy Medical Center

    Baltimore, Maryland 21202
    United States

    Site Not Available

  • National Translational Research Group

    East Setauket, New York 11733
    United States

    Site Not Available

  • Oncology Specialists of Charlotte

    Charlotte, North Carolina 28207
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.